Table 3 Epigenetic regulation of tumor cell cuproptosis
Gene | Title | Epigenetic modulation | Cancer |
|---|---|---|---|
LIPT1/DLAT/ MTF1/GLS… | A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma | Non-coding RNAs | Hepatocellular carcinoma |
LINC01150 | A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer | Non-coding RNAs | Gastric cancer |
LncRNA AL645608.6/AL591767… | A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA | Non-coding RNAs | Osteosarcoma |
RNF139-AS1/LINC00996 NR2F2-AS1… | A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer | Non-coding RNAs | Bladder cancer |
CASC8 | Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer | Non-coding RNAs | Pancreatic cancer |
Cuproptosis-associated lncRNAs | Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma | Non-coding RNAs | Head and neck squamous cell carcinoma |
LINC00853 | Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853 | Non-coding RNAs | Pancreatic Adenocarcinoma |
RAB11B-AS1/AC007552.2/AL035530.2… | Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs | Non-coding RNAs | Uterine corpus endometrial carcinoma |
AC004112.1/AC007064.2/ AC012186.2… | A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma | Non-coding RNAs | Hepatocellular carcinoma |
METTL16/FDX1 | Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer | m6A modification | Gastric cancer |